USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: AMERICAN LABORATORY SUPPLIES
Address: 2000 N 14TH ST, STE 530
ARLINGTON, VA 22201
Located in HUBZone: No
Woman-Owned: Yes
Minority-Owned: Yes
URL: N/A
Phone: (703) 558-3400

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $805,317.00 12
SBIR Phase II $2,813,010.00 5

Award List:

A NEW HAIRY CELL LEUKEMIA CELL LINE

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: Shi-hua Wu
Award Amount: $49,875.00
Abstract:
A new cell line, designated "hds", was established in a suspension culture derived from the peripheral blood of a patient with hairy cell leukemia (hcl), and the person has developed clinical resistance to alpha-interferon therapy. the patient exhibited a clinical picture characteristic of hcl,… More

A NEW CHROMOSOME BAND-SPECIFIC IDENTIFICATION METHOD

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: Han-xiang Deng
Award Amount: $50,000.00

Hematological Diagnosis of Sickle Cell Anemia

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: HHS
Principal Investigator: Gerald L. Kropp
Award Amount: $50,000.00
Abstract:
Sickle cell anemia is an inherited disorder of erythrocytes characterized by chronic anemia, recurrent pain, susceptibility to infections, chronic and recurrent organ dysfunction, and diminished life-expectancy. Even among patients having documented homozygous sickle cell anemia (Hb SS), there… More

INFORMATION SYSTEM FOR PATIENT SELF-CARE

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

New Approach to Cancer Diagnosis and Treatment

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yong-Hua Xu
Award Amount: $50,000.00

Molecular Diagnostic Kits for Beta-Thalassemia

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: HHS
Principal Investigator: Shu-Zhen Huang
Award Amount: $50,000.00

A NEW CHROMOSOME BAND-SPECIFIC IDENTIFICATION METHOD

Award Year / Program / Phase: 1994 / SBIR / Phase II
Agency: HHS
Principal Investigator: Han-xiang Deng
Award Amount: $426,212.00
Abstract:
We will develop a simple chromosome band-specific painting technique, with the direct use of pcr products from microdissected defined chromosomal region as a pool of probes. the tecnique will be standardized and will be further tested during the phase ii period. after the technique/kit is fully… More

Molecular Diagnostic Kits for Beta-Thalassemia

Award Year / Program / Phase: 1994 / SBIR / Phase II
Agency: HHS
Principal Investigator: Shu-Zhen Huang
Award Amount: $500,000.00
Abstract:
Beta-thalassemia is the most common inherited blood disorder. Advances in recombinant DNA and genetic technologies have made Beta-thalassemia the primary genetic disease of multiple mutations. Molecular basis is being characterized for more than 90% of all the defective genes and is leading to new… More

Fetal Hemoglobin Production/Screening

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: HHS
Principal Investigator: Eitan Fibach
Award Amount: $65,000.00

Molecular Diagnosis Kits for Beta Thalassemia

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ivan Ding
Award Amount: $65,000.00

Fetal Hemoglobin Production/Screening

Award Year / Program / Phase: 1995 / SBIR / Phase II
Agency: HHS
Principal Investigator: Eitan Fibach
Award Amount: $490,426.00
Abstract:
Our company will develop an in vitro tissue culture system which will permit studies of drugs'capability to enhance production of fetal hemoglobin. The Investigator stated that increased fetalhemoglobin in cells of patients with beta-hemoglobinopathy ameliorates the clinical symptoms of… More

Molecular Diagnosis Kits for Beta Thalassemia

Award Year / Program / Phase: 1995 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ivan Ding
Award Amount: $668,202.00
Abstract:
We will develop a simple PCR method to diagnosis alpha-thalassemias. Phase I of the project willconduct feasibility study for the development of a non-isotopic sensitive assay to detect the deletionsof five frequently occurring genotypes of alpha-thalassemia using differential PCR. The Investigator… More

New Approach to Cancer Diagnosis and Treatment

Award Year / Program / Phase: 1995 / SBIR / Phase II
Agency: HHS
Principal Investigator: Yong-Hua Xu
Award Amount: $728,170.00
Abstract:
We will utilize conditioned media (CM) from cultures of the nasopharyngeal carcinoma (NPC) cell line CNEI. This cell line was derived from a patient in China and is the only NPC cell line that has been adapted to grow in the absence of serum. Preliminary evidence has established that the CNEI cell… More

NONINVASIVE PRENATAL DIAGNOSIS OF GENETIC DISEASES

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $86,061.00

RAPID GENERATION OF HUMAN CHROMOSOME ARM PAINTING PROBE

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $90,359.00

PRENATAL DIAGNOSIS OF INHERITED BLOOD DISORDERS

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mill, john f
Award Amount: $99,900.00
Abstract:
During pregnancy small numbers of fetal erythrocytes enter the maternal circulation. Among these cells are nucleated erythrocytes called normoblasts. Genomic analysis of these normoblasts using specific probes by in situ hybridization or the polymerase chain reaction (PCR) potentially provides a… More

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xinyuan Guan
Award Amount: $99,122.00